This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Brilla, R. Articles by Husstedt, I.-W. Search for Related Content PubMed PubMed Citation Articles by Brilla, R. Articles by Husstedt, I.-W. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB ACETAZOLAMIDE Related Collections Doppler ultrasound, Transcranial Doppler etc. PET and SPECT Vasculitis Brain Arteries

(Stroke. 1999;30:811-813.)
© 1999 American Heart Association, Inc.

Original Contributions

Cerebral Vasculopathy in HIV Infection Revealed by Transcranial Doppler

A Pilot Study

Roland Brilla, MD; Darius G. Nabavi, MD; Gernot Schulte-Altedorneburg, MD; Vendel Kemény, MD; Doris Reichelt, MD; Stefan Evers, MD; Uwe Schiemann, MD Ingo-W. Husstedt, MD

From the Departments of Neurology (R.B., S.E., D.G.N., G.S.-A., V.K., O.-W.H.) and Internal Medicine D (D.R., U.S.), University of Münster, Münster, Germany.

Correspondence to Ingo-W. Husstedt, MD, Department of Neurology, University of Münster, Albert-Schweitzer-Str. 33, D48129 Münster, Germany.

Background and Purpose—There is growing evidence for affection of cerebral vessels during human immunodeficiency virus (HIV) infection. We prospectively evaluated cerebrovascular reserve capacity (CRC) in HIV-seropositive patients by transcranial Doppler sonography (TCD) after systemic administration of acetazolamide. We hypothesized that a disturbed vasoreactivity would reflect the cerebral arteries' involvement in HIV infection.

Methods—We assessed the mean blood flow velocity (BFV) of the middle cerebral artery and its increase after intravenous administration of 1 g acetazolamide (CRC) in 31 HIV-infected individuals without symptoms of cerebrovascular disease (mean±SD age, 39±11 years). Stenotic or occlusive lesions of the large brain-supplying arteries were excluded by color-coded duplex and transcranial imaging. BFV and CRC were also measured in an age-matched group of 10 healthy control subjects. Patients were classified according to clinical, laboratory, and neurophysiological parameters. We also performed cerebral MRI (n=25) and rheumatological blood tests (n=26).

Results—Baseline BFV and CRC both were significantly reduced in HIV-infected patients as compared with control subjects (P<0.05, Student's t test). These findings did not correlate with duration of seropositivity, helper cell count, or other clinical, rheumatological, and neuroradiological findings.

Conclusions—Our findings support the hypothesis of a cerebral vasculopathy etiologically associated with HIV infection.

Key Words: cerebrovascular circulation • cerebral vasculopathy • HIV • ultrasonography, Doppler, transcranial

This article has been cited by other articles:

				G. Ortiz, S. Koch, J. G. Romano, A. M. Forteza, and A. A. Rabinstein Mechanisms of ischemic stroke in HIV-infected patients Neurology, April 17, 2007; 68(16): 1257 - 1261. [Abstract] [Full Text] [PDF]

				J. W. Cole, A. N. Pinto, J. R. Hebel, D. W. Buchholz, C. J. Earley, C. J. Johnson, R. F. Macko, T. R. Price, M. A. Sloan, B. J. Stern, et al. Acquired Immunodeficiency Syndrome and the Risk of Stroke Stroke, January 1, 2004; 35(1): 51 - 56. [Abstract] [Full Text] [PDF]

				M.D. Connor, G.A. Lammie, J.E. Bell, C.P. Warlow, P. Simmonds, and R.D. Brettle Cerebral Infarction in Adult AIDS Patients : Observations From the Edinburgh HIV Autopsy Cohort Stroke, September 1, 2000; 31(9): 2117 - 2126. [Abstract] [Full Text] [PDF]